The key takeaways from Synlaits presentation is that sales of infant formula in the second half are expected to be much higher than the first half 41% first half 59% second half (that represents a 44% increase on the first half) see Presentation document.
Sales of lactoferrin, which are all China label were up 71% for same period last year (7mt last year first half and 12mts this year) and are expected to continue to accelerate sharply
Growth in demand for IF in January February was significant but they haven't provided guidance on what that might look like over the full second half.
The key takeaways from Synlaits presentation is that sales of...
-
- There are more pages in this discussion • 10,168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.59 |
Change
-0.060(1.06%) |
Mkt cap ! $4.041B | |||
| Open | High | Low | Value | Volume |
| $5.67 | $5.68 | $5.58 | $14.79M | 2.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 38098 | $5.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.62 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| A2M (ASX) Chart |